Literature DB >> 24268924

Eye-of-the-tiger-sign in a 48 year healthy adult.

Simon J A van den Bogaard1, Mark C Kruit2, Eve M Dumas3, Raymund A C Roos3.   

Abstract

We report a healthy adult male, who underwent, as a control subject, part of a Huntington's disease study, extensive testing during three visits in a two year follow-up, including clinical examination and 3.0 T MRI scans. The T2-weighted MRI sequences revealed the "eye-of-the-tiger-sign". No clinical abnormalities in either motor, cognitive or behavioural domains were observed. PKAN2 and FTL gene mutation analysis were negative. This finding implies that an eye-of-the-tiger sign, which is considered a pathognomonic feature of neurodegeneration with brain iron accumulation (NBIA), can occur without any clinical symptoms.
© 2013.

Entities:  

Keywords:  Eye-of-the-tiger sign; Iron; Movement disorder; NBIA; Neuroferritinopathy; PKAN

Mesh:

Year:  2013        PMID: 24268924     DOI: 10.1016/j.jns.2013.10.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Eye of the Tiger Sign and Very Late Onset in Dentatorubral-Pallidoluysian Atrophy.

Authors:  Joana Morgado; Sofia Reimão; Miguel Coelho; Mário M Rosa; Joaquim J Ferreira; Leonor Correia Guedes
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

Review 2.  Animals in the Brain.

Authors:  Eoin Mulroy; Bettina Balint; Matthew E Adams; Tom Campion; Marcelo Merello; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2019-02-28

3.  MR image mimicking the "eye of the tiger" sign in Wilson's disease.

Authors:  T Litwin; M Karlinski; M Skowrońska; K Dziezyc; M Gołębiowski; A Członkowska
Journal:  J Neurol       Date:  2014-03-26       Impact factor: 4.849

4.  Pantothenate kinase-associated neurodegeneration (PKAN) in a child with Down syndrome. A case report and follow-up with MRI.

Authors:  A Hakim; C Rozeik; M Fedorcak
Journal:  BJR Case Rep       Date:  2015-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.